- Report
- November 2025
- 132 Pages
Global
From €863EUR$950USD£745GBP
The Shingles Vaccine is a vaccine used to prevent shingles, a painful skin condition caused by the varicella-zoster virus. It is recommended for adults over the age of 50, and is available in both single-dose and two-dose formulations. The vaccine is typically administered by a healthcare provider, and is available in both private and public healthcare settings.
The Shingles Vaccine market is a subset of the larger Vaccines market, which is estimated to be worth billions of dollars. The Shingles Vaccine market is expected to grow in the coming years, driven by an aging population and increased awareness of the condition.
Some of the major companies in the Shingles Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more